3Shaw MJ,Talley NJ,Beehe TJ, et al . Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease[J]. Am J Gastroenterol , 2001,96(1):52-57.
4Johnsson F, Hatlebakk J G, Klintenberg AC, et al . Symptomerelieving effectof esomeprazole 40 mg daily in patients with heartburn[J]. Scand J Gastroenterol , 2003,38(4) : 347-353.
2An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut, 1999,44 Suppl 2 : S1-S16.
3Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)-acid reflux and symptom pattern. Aliment Pharmacol Ther, 2003,17:537-545.
4Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease:current concept and dilemmas. Am J Gastroenterol, 2001,96:303-314.
5Pace F, BoUani S, Molteni P, et al. Natural history of gastrooesophageal reflux disease without oesophagitis (NERD):a reappraisal 10 years on. Dig Liver Dis, 2004,36:111-115.
6Peghini PL, Katz PO, Bracy NA, et all Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol, 1998,93:763-767.
7Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol, 1997,32:974-979.
8Fass R, Tougas G. Functional heartburn : the stimulus, the pain,and the brain. Gut, 2003,51:885-892.
9Drossman DA. The functional gastrointestinal disorders and the Rome Ⅱ process. Gut,1999,45 Suppl 2 :Ⅱ 1-5.
10Just RJ, Lelte LP, Castell DO. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects. Am J Gastroenterol, 1996,91:1567-1570.
